Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
13.77%
Price
15:43
€316.35
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 13.77%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.953% | 3.953% |
| iShares Core DAX® | 0,36 % | -0,24 % |
| iShares Nasdaq 100 | 2,59 % | 1,79 % |
| iShares Nikkei 225® | 1,80 % | 7,12 % |
| iShares S&P 500 | 1,20 % | 0,93 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat